EVT vs Medical Therapy in Large-Core Ischemic Stroke

Endovascular thrombectomy (EVT) drastically transforms modern intervention strategies for patients presenting with a large-core ischemic stroke. Historically, clinicians limited invasive mechanical thrombectomy to patients with small infarct cores due to fears of reperfusion hemorrhage. However, recent landmark clinical evidence confirms that EVT substantially improves functional independence in extended time windows up to 24 hours.

Clinical Impact in Large-Core Ischemic Stroke

Additionally, medical therapy alone often leaves patients with severe neurological deficits and high mortality rates. In contrast, combining mechanical thrombectomy with standard medical management significantly enhances recovery scores at 90 days. Furthermore, EVT reduces all-cause mortality while maintaining a safe risk profile regarding symptomatic intracranial hemorrhage.

Therefore, emergency medical teams must rapidly identify eligible candidates using advanced neuroimaging. Consequently, prompt triage expands access to life-saving arterial recanalization for acute stroke patients across healthcare centers.

Key Guidelines for Clinical Practice

Specifically, neurointerventionalists evaluate patients presenting between 6 and 24 hours from symptom onset or last known well. Moreover, non-contrast CT and CT perfusion imaging reliably demarcate established infarct boundaries. Thus, physicians can confidently select patients who will benefit from endovascular intervention despite initial large lesion volume.

Overall, extending the treatment window to 24 hours offers crucial therapeutic options for late-arriving patients. Ultimately, incorporating these evidence-based practices into clinical protocol improves patient survival and quality of life.

Frequently Asked Questions

Q1: What is the primary benefit of EVT in large-core ischemic stroke?

EVT significantly improves 90-day functional independence and reduces overall mortality compared to medical therapy alone.

Q2: What time window is effective for EVT in large-core stroke?

Clinical trials demonstrate that EVT provides clear therapeutic benefits when initiated within 24 hours of symptom onset.

Q3: Does EVT increase the risk of symptomatic intracranial hemorrhage?

Although mechanical thrombectomy carries inherent procedural risks, overall clinical benefits far outweigh the risk profile in eligible patients.

References

1. Srivastava A et al. In large-core ischemic stroke with onset in the past 24 h, EVT vs. medical therapy improves functional outcomes and reduces mortality at 90 d. Ann Intern Med. 2026 Aug 04. doi: 10.7326/ANNALS-26-02780-JC. PMID: 42546311.
2. Sarraj A, Thomalla G, Yoshimura S, et al. Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset: a systematic review and meta-analysis. Lancet Neurol. 2024.
3. American Heart Association. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2026.